GLYCAEMIC, ANTHROPOMETRIC, AND LIPID OUTCOMES OF CDC DM PACKAGE INTERVENTION IN 10 COMPLEX T2DM PATIENTS AT NAVI MUMBAI–PANVEL: A PILOT RETROSPECTIVE ANALYSIS

Background: Navi Mumbai-Panvel's DM Package cohort (n=10), while small, includes patients with complex comorbidities (DM+CAD, DM+IHD, multi-system disease) and 100% medication reduction documentation. This pilot analysis evaluates protocol efficacy in a complex, high-cardiovascular-risk diabetic population. Objective: To evaluate the effect of the Madhavbaug CDC Panchakarma-based multimodal protocol on glycaemic, anthropometric, cardiometabolic, and medication parameters exclusively in DM Package patients (n=10) at the Navi Mumbai (Panvel) Central RIC clinic. Methods: Retrospective observational study. 10 T2DM patients enrolled in the DM Package at Navi Mumbai (Panvel) Central RIC. Only DM Package care plans (CDC-SP Base/1/2/3, CDC-KP Base/1/2/3, DM-HTN 1/2/3) included. Paired Student's t-test (two-tailed) for within-group pre–post comparisons (p<0.05 significant). Descriptive statistics as mean ± SD. Results: RBS reduced significantly from 229.80±81.28 to 142.40±44.58 mg/dL (Δ −87.40 mg/dL, −38.0%, p<0.001, n=10). Weight fell by −4.78 kg (−6.4%, p=0.002). BMI −2.02 kg/m² (−6.9%, p=0.003). Abdominal girth −4.90 cm (−5.0%, p=0.003). DBP −5.40 mmHg (−6.1%, p=0.033). Total cholesterol showed a clinically meaningful reduction of −35.40 mg/dL (−18.1%, p=0.069, n=8). Triglycerides reduced by −27.05 mg/dL (−10.4%, p=0.040, n=8). All 10 patients achieved partial medication reduction (100% partial medication reduction rate). Conclusion: Despite its small sample (n=10), Navi Mumbai-Panvel's DM Package demonstrates exceptional results: RBS −38.0% (p<0.001), weight −6.4% (p=0.002), BMI −6.9% (p=0.003), abdominal girth −5.0% (p=0.003), triglycerides −10.4% (p=0.040), and DBP −6.1% (p=0.033). The 100% partial medication reduction rate and clinically meaningful lipid trends represent the strongest combined anthropometric and pharmacoeconomic outcomes in the Central RIC DM network.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-05-30
DOI
https://doi.org/10.5281/zenodo.20465568
Primary Topic
Diabetes, Cardiovascular Risks, and Lipoproteins
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

GLYCAEMIC, ANTHROPOMETRIC, AND LIPID OUTCOMES OF CDC DM PACKAGE INTERVENTION IN 10 COMPLEX T2DM PATIENTS AT NAVI MUMBAI–PANVEL: A PILOT RETROSPECTIVE ANALYSIS

Dr. Rohit Sane1, Dr. Gurudatta Amin2, Dr. Pravin Ghadigaonkar3, Dr. Nilesh Kulthe*4, Dr. Priyanka Salwade5
Zenodo (CERN European Organization for Nuclear Research)
Diabetes, Cardiovascular Risks, and Lipoproteins
article

GLYCAEMIC, ANTHROPOMETRIC, AND LIPID OUTCOMES OF CDC DM PACKAGE INTERVENTION IN 10 COMPLEX T2DM PATIENTS AT NAVI MUMBAI–PANVEL: A PILOT RETROSPECTIVE ANALYSIS

Dr. Rohit Sane1, Dr. Gurudatta Amin2, Dr. Pravin Ghadigaonkar3, Dr. Nilesh Kulthe*4, Dr. Priyanka Salwade5
article en

Abstract

Background: Navi Mumbai-Panvel's DM Package cohort (n=10), while small, includes patients with complex comorbidities (DM+CAD, DM+IHD, multi-system disease) and 100% medication reduction documentation. This pilot analysis evaluates protocol efficacy in a complex, high-cardiovascular-risk diabetic population. Objective: To evaluate the effect of the Madhavbaug CDC Panchakarma-based multimodal protocol on glycaemic, anthropometric, cardiometabolic, and medication parameters exclusively in DM Package patients (n=10) at the Navi Mumbai (Panvel) Central RIC clinic. Methods: Retrospective observational study. 10 T2DM patients enrolled in the DM Package at Navi Mumbai (Panvel) Central RIC. Only DM Package care plans (CDC-SP Base/1/2/3, CDC-KP Base/1/2/3, DM-HTN 1/2/3) included. Paired Student's t-test (two-tailed) for within-group pre–post comparisons (p<0.05 significant). Descriptive statistics as mean ± SD. Results: RBS reduced significantly from 229.80±81.28 to 142.40±44.58 mg/dL (Δ −87.40 mg/dL, −38.0%, p<0.001, n=10). Weight fell by −4.78 kg (−6.4%, p=0.002). BMI −2.02 kg/m² (−6.9%, p=0.003). Abdominal girth −4.90 cm (−5.0%, p=0.003). DBP −5.40 mmHg (−6.1%, p=0.033). Total cholesterol showed a clinically meaningful reduction of −35.40 mg/dL (−18.1%, p=0.069, n=8). Triglycerides reduced by −27.05 mg/dL (−10.4%, p=0.040, n=8). All 10 patients achieved partial medication reduction (100% partial medication reduction rate). Conclusion: Despite its small sample (n=10), Navi Mumbai-Panvel's DM Package demonstrates exceptional results: RBS −38.0% (p<0.001), weight −6.4% (p=0.002), BMI −6.9% (p=0.003), abdominal girth −5.0% (p=0.003), triglycerides −10.4% (p=0.040), and DBP −6.1% (p=0.033). The 100% partial medication reduction rate and clinically meaningful lipid trends represent the strongest combined anthropometric and pharmacoeconomic outcomes in the Central RIC DM network.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 6%
Diabetes, Cardiovascular Risks, and Lipoproteins
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.